Ignite Creation Date:
2024-05-06 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05091749
Status:
UNKNOWN
Last Update Posted:
2021-12-21
First Post:
2021-10-13
Brief Title:
Detection of Significant Coronary Artery Disease by Promising Biomarker A2A Adenosine Receptor A2AR Assays
Sponsor:
Assistance Publique Hopitaux De Marseille
Organization:
Assistance Publique Hopitaux De Marseille
Study Overview
Official Title:
Detection of Significant Coronary Artery Disease by Promising Biomarker A2A Adenosine Receptor A2AR Assays
Status:
UNKNOWN
Status Verified Date:
2021-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ADOCAD
Brief Summary:
Transversal national multi-center study with progressive recruitment designed to assess the diagnostic accuracy of A2AR expression for the identification of significant obstructive CAD FFR08 of patients suspected of CCS compared to the gold standard
1 To assess the diagnostic accuracy of the A2AR profile ie KDEC50 for identifying myocardial ischemia in patients with suspected CCS compared to the gold standard inducible myocardial ischemia
2 To determine the best threshold value for A2AR expression for identifying significant obstructive CAD FFR08 in patients with CCS and to estimate the diagnostic performances associated with the identified threshold
3 To determine the best threshold value for A2AR profile ie KDEC50 for identifying myocardial ischemia See annex 2 in patients with CCS and to estimate the diagnostic performances associated with the identified threshold
1 To assess the diagnostic accuracy of the A2AR profile ie KDEC50 for identifying myocardial ischemia in patients with suspected CCS compared to the gold standard inducible myocardial ischemia
2 To determine the best threshold value for A2AR expression for identifying significant obstructive CAD FFR08 in patients with CCS and to estimate the diagnostic performances associated with the identified threshold
3 To determine the best threshold value for A2AR profile ie KDEC50 for identifying myocardial ischemia See annex 2 in patients with CCS and to estimate the diagnostic performances associated with the identified threshold
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2021-A02200-41 | OTHER | IDRCB | None |